Korro Bio reported earnings of -$ 0.98 per KRRO share on Nov 5, 2026, falling short of analysts' expectations by
| Report Date | Nov 5, 2026 |
|---|---|
| Forecasted EPS | -$ 1.14 |
| Earnings Per Share (Surprise) | -$ 0.98 (+$ 0.16) |
| Last Year's EPS | -$ 3.12 |
| EPS YoY Change |
Out of the last 32 earnings reporting periods, Korro Bio beat analysts’ expectations 14 times and fell short of expectations 8 time(s). Korro Bio reported earnings per share of -$ 0.98 in the last report surpassing an estimated EPS of -$ 1.14 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 1.14 | -$ 0.98 | -$ 1.92 | |
| Aug 6, 2026 | -$ 1.34 | -$ 1.07 | -$ 2.74 | |
| May 7, 2026 | -$ 1.60 | -$ 1.69 | -$ 2.49 | |
| Mar 12, 2026 | -$ 1.93 | -$ 5.32 | -$ 2.26 | |
| Nov 12, 2025 | -$ 2.61 | -$ 1.92 | -$ 2.26 | |
| Aug 12, 2025 | -$ 2.54 | -$ 2.74 | -$ 2.43 | |
| May 7, 2025 | -$ 2.60 | -$ 2.49 | -$ 2.44 | |
| Mar 18, 2025 | -$ 2.33 | -$ 2.26 | -$ 25.65 | |
| Nov 12, 2024 | -$ 2.55 | -$ 2.26 | -$ 25.65 | |
| Aug 13, 2024 | -$ 2.40 | -$ 2.43 | -$ 15.50 | |
| May 14, 2024 | -$ 2.36 | -$ 2.44 | -$ 15.00 | |
| Mar 29, 2024 | -$ 2.36 | -$ 25.65 | -$ 27.50 | |
| Mar 26, 2024 | -$ 2.36 | -$ 25.65 | -$ 24.50 | |
| Nov 2, 2023 | -$ 17.73 | -$ 15.50 | -$ 3.21 | |
| Aug 10, 2023 | -$ 17.80 | -$ 15.00 | -$ 27.50 | |
| May 12, 2023 | -$ 21.00 | -$ 27.50 | -$ 3.74 | |
| Mar 10, 2023 | -$ 31.55 | -$ 24.50 | -$ 30.43 | |
| Dec 30, 2022 | -$ 31.55 | -$ 3.21 | -$ 33.59 | |
| Nov 8, 2022 | -$ 28.50 | -$ 27.50 | -$ 31.07 | |
| Sep 29, 2022 | -$ 28.50 | -$ 3.74 | -$ 36.51 |
Korro Bio’s stock was trading at $ 16.62 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, KRRO’s price decreased to $ 14.75 on Nov 6, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.98 | $ 16.62 | $ 14.75 | |
| Aug 6, 2026 | -$ 1.07 | $ 11.50 | $ 13.25 | |
| May 7, 2026 | -$ 1.69 | $ 13.34 | $ 12.05 | |
| Mar 12, 2026 | -$ 5.32 | $ 11.76 | $ 12.80 | |
| Nov 12, 2025 | -$ 1.92 | $ 32.80 | $ 6.50 | |
| Aug 12, 2025 | -$ 2.74 | $ 15.05 | $ 18.93 | |
| May 7, 2025 | -$ 2.49 | $ 14.80 | $ 15.40 | |
| Mar 18, 2025 | -$ 2.26 | $ 25.06 | $ 23.72 | |
| Nov 12, 2024 | -$ 2.26 | $ 73.50 | $ 55.01 | |
| Aug 13, 2024 | -$ 2.43 | $ 35.97 | $ 39.71 | |
| May 14, 2024 | -$ 2.44 | $ 50.24 | $ 52.77 | |
| Mar 29, 2024 | -$ 25.65 | $ 90.00 | $ 89.74 | |
| Mar 26, 2024 | -$ 25.65 | $ 73.42 | $ 88.53 | |
| Nov 2, 2023 | -$ 15.50 | $ 12.40 | $ 15.00 | |
| Aug 10, 2023 | -$ 15.00 | $ 35.50 | $ 34.05 | |
| May 12, 2023 | -$ 27.50 | $ 18.65 | $ 17.60 | |
| Mar 10, 2023 | -$ 24.50 | $ 31.00 | $ 31.95 | |
| Dec 30, 2022 | -$ 3.21 | $ 162.00 | $ 197.50 | |
| Nov 8, 2022 | -$ 27.50 | $ 113.00 | $ 106.50 | |
| Sep 29, 2022 | -$ 3.74 | $ 95.00 | $ 89.50 |
Korro Bio released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Korro Bio beat analysts’ expectations during the last earnings period by
